# Felipe Camposano

> Felipe Camposano is a seed investor at Taram Capital backing Software and Information Technology. See 17 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Taram Capital](https://shizune.co/investors/profile/taram-capital)
- Location: Miami, United States
- Total investments: 17
- Last investment: Aug 2024
- Lead investor: 29%
- Last updated: Aug 2026
- LinkedIn: https://co.linkedin.com/pub/felipe-camposano/1/9a0/7a6

Felipe Camposano is a seed investor at Taram Capital in Miami focused on Software and Information Technology. Felipe Camposano also serves as Strategic Planning Chair for the ASEM-BIO (The Chilean Biotechnology Association). He currently holds board seats at Lucien Biotech (which he co-founded), and at the Agro Biotech Center of DICTUC, the technology transfer arm of Universidad Católica de Chile.Prior to joining Austral, Felipe directed New BusinessDevelopment at Fundación Chile where he created and invested in new technology companies. Felipe was founder and CEO of INTRA, delivering enterprise knowledge management solutions to Global 1000 firms and was co-founder of NEXION, providing technology development services to Latin American companies in China. He has served as consultant and advisor at CORFO-Invest and ProChile, promoting international investment in Chile; new project valuation at OPS&S in Argentina, Brazil and Chile; and technology advisor to CORFO-Innova, the Chilean Development Agency. Filipe has taught the Technology Entrepreneur Marketing course at Universidad Católica de Chile, written the investor column at BioNexa (RedCiencia) and won national and international innovation awards for his patents (PCT/IB2007/050917).Felipe holds a BSc. in Computer Sciences and a MSc. in Industrial Engineering from Universidad Católica de Chile.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 6 | 35% |
| Information Technology | 5 | 29% |
| Enterprise Software | 3 | 18% |
| SaaS | 2 | 12% |
| Medical | 2 | 12% |

40 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 4 | 24% |
| Series A | 4 | 24% |
| Series B | 3 | 18% |
| Funding Round | 3 | 18% |
| Angel | 1 | 6% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Chile | 7 | 41% |
| United States | 6 | 35% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Andes STR | Want to become part of something BIG? Andes STR is a PropTech startup that is revolutionizing how people invest in short-term rental property, making it easier than ever. We recently won 1st place in University of Chicago's 25th New Venture Challenge, and we're backed by the most prominent Midwest US VC firms; our investors were earlysupporters of companies such as Airbnb, Tesla, SpaceX, Uber, and our founders are industry veterans with an impeccable track record.We are developing a platform that uses Machine Learning to make it easy for customers to buy the best short-term rental properties for investment purposes. Using our platform, in a matter of minutes customers are able to buy a property that can be rented to guests by the night for income, or be used by the owners whenever they want. Customers don't have to worry about finding good deals, negotiating prices, inspections, financing, furnishing, or keeping their guests happy - we take care of everything for our customers for a truly seamless and turnkey experience! | $4M | Venture - Series Unknown | Aug 14, 2024 |  |
| Keirón | Keiron develops software and online tools to manage healthcare services and processes. It provides digital solutions on making hospital schedules, ordering goods from pharmacies, and arranging patient information. Keiron was founded in 2019 and has operations in Mexico, Chile and Perú | $1.7M | Seed | Mar 01, 2024 |  |
| Radar Treasury | Radar helps companies in Latin America to perform their bank transfers without human intervention. Radar created the first payouts to bank accounts API in Chile. | $410K | Angel | May 31, 2022 |  |
| SimpliRoute | SimpliRoute is an information technology company that specializes in the optimization, logistics, innovation, and big data. The company is dedicated to process optimization by means of designing innovative technological solutions for highly complex problems. SimpliRoute was founded in 2015 and headquartered in Santiago, Region Metropolitana. | $8M | Series B | Dec 06, 2021 |  |
| Webdox | Webdox is a SaaS CLM focused on large and medium companies in LATAM and the US. Webdox control automates and optimizes the entire contract lifecycle for all kinds of contract types with different features for the whole contract lifecycle, including contract request, contract drafting, validation, e-signature, contract execution, contract changemanagement, contract repository, and reports.The company was founded in 2017 and headquartered in Region Metropolitana, Chile. | $7.3M | Series A | Oct 25, 2021 |  |
| SimpliRoute | SimpliRoute is an information technology company that specializes in the optimization, logistics, innovation, and big data. The company is dedicated to process optimization by means of designing innovative technological solutions for highly complex problems. SimpliRoute was founded in 2015 and headquartered in Santiago, Region Metropolitana. |  | Series A | Oct 04, 2021 |  |
| Yapp | Yapp is a health tech application that offers medicine deliveries. | $2.6M | Seed | Jan 01, 2021 |  |
| Andes Biotechnologies | Andes Biotechnologies is a leading nucleic acid-based drug discovery and development company focused on solid tumor cancers. The Company has discovered two novel families of long non-coding RNAs: sense (S-RNA) and antisense (AS-RNA). Both are present in all human cells, are synthesized in the mitochondria and migrate to the nucleus.Theproprietary technology developed by Andes Biotechnologies is based on oligonucleotide drugs that target the novel long non-coding regulatory RNAs in tumor cells inducing apoptosis.Andes Biotechnologies has an active investigational new drug (IND) application in the United States and is currently engaged in the clinical development of its lead drug Andes-1537.Andes Biotechnologies is supported by a proven and experienced management team, a robust network of key national and international collaborators in the cancer field, and has an extensive intellectual property portfolio.Andes Biotechnologies was founded in 2008 and is located in Santiago, Chile. |  |  | Dec 23, 2014 |  |
| Scopix | SCOPIX is the market leader in intelligent video analytics for retailers, CPG companies and manufactures. Our Real.Suite ™ family of cloud based solutions collects data and returns timely, actionable information via a web based portal to store personnel, regional managers and corporate executives to help them maximize the customer experiencethroughout the entire store. SCOPIX solutions are proven to enhance retail business operations, drive sales and maximize profits. | $4.8M |  | Jul 02, 2012 |  |
| Junar | Junar powers the Data Economy by delivering the easiest-to-use, cloud-based Open Data platform. For innovative organizations, Junar is the fastest way to publish data. The Junar platform enables businesses, governments, and organizations to free their data to drive new opportunities, collaboration, and transparency. Some of the world'sleading companies trust Junar with their most valuable assets: their data and the end users who are viewing and using it. | $1.2M | Seed | May 29, 2012 |  |

10 of 17 investments shown.

## Co-investors
- [Aurus](https://shizune.co/investors/profile/aurus) — VC Fund, 2 deals together
- [TheVentureCity](https://shizune.co/investors/profile/the-venture-city) — VC Fund, 2 deals together
- [Alacrity Ventures](https://shizune.co/investors/profile/alacrity-ventures) — VC Fund, 1 deal together
- [Asenza Capital](https://shizune.co/investors/profile/asenza-capital) — VC Fund, 1 deal together
- [Band of Angels](https://shizune.co/investors/profile/band-of-angels) — VC Fund, 1 deal together
- [ChileGlobal Angels](https://shizune.co/investors/profile/chileglobal-angels) — VC Fund, 1 deal together

## About Taram Capital

VC Fund · Santiago, Chile

We invest in teams that are transforming their industries with B2B technological solutions for SMEs and large companies, with an emphasis on the eCommerce, Fintech, Data Driven Solutions, and Web3 sectors.We focus on early-stage companies, investing in Late Seed and Series A, in startups with a presence in Chile and international projections,whose solutions address cross-cutting problems for companies worldwide.

3 contacts available at Taram Capital.

| Name | Title | Profile |
| --- | --- | --- |
| David Herranz | Venture Partner | https://shizune.co/investors/profile/david-herranz-049c |
| Felipe Camposano | Managing Partner | https://shizune.co/investors/profile/felipe-camposano |
| Francisco Marin | Associate | https://shizune.co/investors/profile/francisco-marin-9ccc |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Felipe Camposano invest in?

Felipe Camposano invests primarily in Software, Information Technology and Enterprise Software startups, most often at Seed and Series A stage. Most of the 17 investments tracked by Shizune back companies in Chile. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Felipe Camposano last invest?

The most recent investment recorded for Felipe Camposano closed in Aug 2024. Shizune tracks 17 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co